Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assembles World-Class Advisory Board
Initially developed for atopic dermatitis, Enveda's lead asset ENV-294 is now showing promise in treating asthma.
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 16,500 ...
MM&M3h
Inside Eli Lilly’s bold breast cancer awareness ad debut at the Grammys
Eli Lilly’s latest TV ad, unveiled during the Grammys on Sunday night, highlights the importance of early diagnosis for ...
Too Old to Operate10h
Impact of Dupilumab on Skin Protein and Metabolite Composition in AD
The following is a summary of “Longitudinal integrated proteomic and metabolomic skin changes in atopic dermatitis patients ...
verywellhealth21h
13 Natural Remedies and Alternative Therapies to Help Cope With Depression
While there are many treatment options for depression, natural remedies, self-care methods, and alternative therapies can ...
These are the ingredients that will actually target cellulite, according to dermatologists
Wondering how to reduce cellulite on your legs or arms? Derms share their tips, from dry brushing for cellulite to using ...